These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
522 related articles for article (PubMed ID: 29280743)
1. Current Nomenclature of Pseudohypoparathyroidism: Inactivating Parathyroid Hormone/Parathyroid Hormone-Related Protein Signaling Disorder. Turan S J Clin Res Pediatr Endocrinol; 2017 Dec; 9(Suppl 2):58-68. PubMed ID: 29280743 [TBL] [Abstract][Full Text] [Related]
2. Identification of novel pathogenic variants and features in patients with pseudohypoparathyroidism and acrodysostosis, subtypes of the newly classified inactivating PTH/PTHrP signaling disorders. Truelove A; Mulay A; Prapa M; Casey RT; Adler AI; Offiah AC; Poole KES; Trotman J; Al Hasso N; Park SM Am J Med Genet A; 2019 Jul; 179(7):1330-1337. PubMed ID: 31041856 [TBL] [Abstract][Full Text] [Related]
3. GNAS epigenetic defects and pseudohypoparathyroidism: time for a new classification? Mantovani G; Elli FM; Spada A Horm Metab Res; 2012 Sep; 44(10):716-23. PubMed ID: 22674477 [TBL] [Abstract][Full Text] [Related]
4. Pseudohypoparathyroidism type Ib in 2015. Mantovani G; Elli FM Ann Endocrinol (Paris); 2015 May; 76(2):101-4. PubMed ID: 25910998 [TBL] [Abstract][Full Text] [Related]
5. The GNAS locus and pseudohypoparathyroidism. Bastepe M Adv Exp Med Biol; 2008; 626():27-40. PubMed ID: 18372789 [TBL] [Abstract][Full Text] [Related]
6. Genetics and epigenetics of parathyroid hormone resistance. Bastepe M Endocr Dev; 2013; 24():11-24. PubMed ID: 23392091 [TBL] [Abstract][Full Text] [Related]
7. GNAS locus and pseudohypoparathyroidism. Bastepe M; Jüppner H Horm Res; 2005; 63(2):65-74. PubMed ID: 15711092 [TBL] [Abstract][Full Text] [Related]
8. Pseudohypoparathyroidism and GNAS epigenetic defects: clinical evaluation of albright hereditary osteodystrophy and molecular analysis in 40 patients. Mantovani G; de Sanctis L; Barbieri AM; Elli FM; Bollati V; Vaira V; Labarile P; Bondioni S; Peverelli E; Lania AG; Beck-Peccoz P; Spada A J Clin Endocrinol Metab; 2010 Feb; 95(2):651-8. PubMed ID: 20061437 [TBL] [Abstract][Full Text] [Related]
10. [Clinical features of two cases of pseudohypoparathyroidism (ia and ib) and molecular analysis of GNAS]. Domínguez García A; Castaño González LA; Pérez-Nanclares G; Quinteiro González S; Caballero Fernández E An Pediatr (Barc); 2013 Nov; 79(5):319-24. PubMed ID: 23623851 [TBL] [Abstract][Full Text] [Related]
11. Gsα activity is reduced in erythrocyte membranes of patients with psedohypoparathyroidism due to epigenetic alterations at the GNAS locus. Zazo C; Thiele S; Martín C; Fernandez-Rebollo E; Martinez-Indart L; Werner R; Garin I; ; Hiort O; Perez de Nanclares G J Bone Miner Res; 2011 Aug; 26(8):1864-70. PubMed ID: 21351142 [TBL] [Abstract][Full Text] [Related]
12. Parathyroid hormone resistance syndromes - Inactivating PTH/PTHrP signaling disorders (iPPSDs). Elli FM; Pereda A; Linglart A; Perez de Nanclares G; Mantovani G Best Pract Res Clin Endocrinol Metab; 2018 Dec; 32(6):941-954. PubMed ID: 30665554 [TBL] [Abstract][Full Text] [Related]
13. Epigenetic defects of GNAS in patients with pseudohypoparathyroidism and mild features of Albright's hereditary osteodystrophy. de Nanclares GP; Fernández-Rebollo E; Santin I; García-Cuartero B; Gaztambide S; Menéndez E; Morales MJ; Pombo M; Bilbao JR; Barros F; Zazo N; Ahrens W; Jüppner H; Hiort O; Castaño L; Bastepe M J Clin Endocrinol Metab; 2007 Jun; 92(6):2370-3. PubMed ID: 17405843 [TBL] [Abstract][Full Text] [Related]
14. Cognitive impairment is prevalent in pseudohypoparathyroidism type Ia, but not in pseudopseudohypoparathyroidism: possible cerebral imprinting of Gsalpha. Mouallem M; Shaharabany M; Weintrob N; Shalitin S; Nagelberg N; Shapira H; Zadik Z; Farfel Z Clin Endocrinol (Oxf); 2008 Feb; 68(2):233-9. PubMed ID: 17803690 [TBL] [Abstract][Full Text] [Related]
15. Molecular analysis of the GNAS1 gene for the correct diagnosis of Albright hereditary osteodystrophy and pseudohypoparathyroidism. De Sanctis L; Romagnolo D; Olivero M; Buzi F; Maghnie M; Scirè G; Crino A; Baroncelli GI; Salerno M; Di Maio S; Cappa M; Grosso S; Rigon F; Lala R; De Sanctis C; Dianzani I Pediatr Res; 2003 May; 53(5):749-55. PubMed ID: 12621129 [TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of methylation defects and correlation with clinical characteristics in patients with pseudohypoparathyroidism type I and GNAS epigenetic alterations. Elli FM; de Sanctis L; Bollati V; Tarantini L; Filopanti M; Barbieri AM; Peverelli E; Beck-Peccoz P; Spada A; Mantovani G J Clin Endocrinol Metab; 2014 Mar; 99(3):E508-17. PubMed ID: 24423294 [TBL] [Abstract][Full Text] [Related]
17. A severe inactivating PTH/PTHrP signaling disorder type 2 in a patient carrying a novel large deletion of the GNAS gene: a case report and review of the literature. Brancatella A; Mantovani G; Elli FM; Borsari S; Marcocci C; Cetani F Endocrine; 2020 Feb; 67(2):466-472. PubMed ID: 31939093 [TBL] [Abstract][Full Text] [Related]
18. Association of GNAS imprinting defects and deletions of chromosome 2 in two patients: clues explaining phenotypic heterogeneity in pseudohypoparathyroidism type 1B/iPPSD3. Elli FM; deSanctis L; Maffini MA; Bordogna P; Tessaris D; Pirelli A; Arosio M; Linglart A; Mantovani G Clin Epigenetics; 2019 Jan; 11(1):3. PubMed ID: 30616679 [TBL] [Abstract][Full Text] [Related]
19. Follow-up Findings in a Turkish Girl with Pseudohypoparathyroidism Type Ia Caused by a Novel Heterozygous Mutation in the GNAS Gene. Şahin S; Hiort O; Thiele S; Evliyaoğlu O; Tüysüz B J Clin Res Pediatr Endocrinol; 2017 Mar; 9(1):74-79. PubMed ID: 27425121 [TBL] [Abstract][Full Text] [Related]